← FDA DRUG APPROVALS

FDA ANDA · ANDA075050

ALBUTEROL SULFATE

Sponsor: BAUSCH

APPLICATION
ANDA075050
TYPE
ANDA
ORIGINAL APPROVAL
1998-06-18
LATEST ACTION
2017-03-31
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

ALBUTEROL SULFATEDiscontinued
ALBUTEROL SULFATE EQ 0.5% BASE · SOLUTION · INHALATION

Approval history

2017-03-31Labeling · Supplement 17 · standardAP
2001-11-27Manufacturing (CMC) · Supplement 9AP
2001-03-07Manufacturing (CMC) · Supplement 7AP
2000-06-27Manufacturing (CMC) · Supplement 6AP
2000-05-18Manufacturing (CMC) · Supplement 2AP
2000-04-28Manufacturing (CMC) · Supplement 3AP
1999-12-29Manufacturing (CMC) · Supplement 5AP
1999-12-29Labeling · Supplement 4AP
1998-06-18OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →